Mitochondrial respiratory complex I dysfunction promotes tumorigenesis through ROS alteration and AKT activation

126Citations
Citations of this article
125Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Previously, we have shown that a heteroplasmic mutation in mitochondrial DNA-encoded complex I ND5 subunit gene resulted in an enhanced tumorigenesis through increased resistance to apoptosis. Here we report that the tumorigenic phenotype associated with complex I dysfunction could be reversed by introducing a yeast NADH quinone oxidoreductase (NDI1) gene. The NDI1 mediated electron transfer from NADH to Co-Q, bypassed the defective complex I and restored oxidative phosphorylation in the host cells. Alternatively, suppression of complex I activity by a specific inhibitor, rotenone or induction of oxidative stress by paraquat led to an increase in the phosphorylation of v-AKT murine thymoma viral oncogene (AKT) and enhanced the tumorigenesis. On the other hand, antioxidant treatment can ameliorate the reactive oxygen species-mediated AKT activation and reverse the tumorigenicity of complex I-deficient cells. Our results suggest that complex I defects could promote tumorigenesis through induction of oxidative stress and activation of AKT pathway. © The Author 2011. Published by Oxford University Press. All rights reserved.

Cite

CITATION STYLE

APA

Sharma, L. K., Fang, H., Liu, J., Vartak, R., Deng, J., & Bai, Y. (2011). Mitochondrial respiratory complex I dysfunction promotes tumorigenesis through ROS alteration and AKT activation. Human Molecular Genetics, 20(23), 4605–4616. https://doi.org/10.1093/hmg/ddr395

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free